ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise the 2007 Clinical Competence Statement on Cardiac Interventional Procedures)

Catheterization and Cardiovascular Interventions

Volumn 82, Issue 2, 2013, Pages

[No Author Info available]

Author keywords

ACCF AHA ACP Clinical Competence Statement; angioplasty, balloon, coronary; clinical competence; coronary disease; peer review, healthcare; percutaneous coronary intervention; quality assurance; quality improvement

Indexed keywords

ALCOHOL SEPTAL ABLATION; ARTICLE; CLINICAL COMPETENCE; COMPLICATION; DOCUMENTATION; EDUCATION PROGRAM; HEART SURGERY; HOSPITAL; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LEARNING CURVE; MEDICAL SOCIETY; PEER REVIEW; PERCUTANEOUS CORONARY INTERVENTION; PROFESSIONAL SECRECY; QUALITY CONTROL; RADIAL ARTERY; RISK ASSESSMENT; VASCULAR ACCESS;

ACCF/AHA/ACP CLINICAL COMPETENCE STATEMENT; ANGIOPLASTY, BALLOON, CORONARY; CLINICAL COMPETENCE; CORONARY DISEASE; PEER REVIEW, HEALTHCARE; PERCUTANEOUS CORONARY INTERVENTION; QUALITY ASSURANCE; QUALITY IMPROVEMENT;

ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CATHETERIZATION; CLINICAL COMPETENCE; CONSENSUS; CORONARY ARTERY DISEASE; EDUCATION, MEDICAL, GRADUATE; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; RISK FACTORS; TREATMENT OUTCOME;

EID: 84880583192     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24985     Document Type: Article

References (168)

1. S.B. King III, T. Aversano, W.L. Ballard, et al., ACCF/AHA/SCAI 2007 update of the clinical competence statement on cardiac interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training, J Am Coll Cardiol 50 (2007) 82-108.
2. G.N. Levine, E.R. Bates, J.C. Blankenship, et al., 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions, J Am Coll Cardiol 58 (2011) e44-e122.
3. ACGME Program Requirements for Graduate Medical Education in Interventional Cardiology (Internal Medicine). Available at: http://www.acgme.org/acgmeweb/Portals/0/PFAssets/ProgramRequirements/ 152-interventional-card-int-med-07012012-1-YR.pdf. Accessed October 12, 2012.
4. G.A. Beller, R.O. Bonow, V. Fuster, ACCF 2008 recommendations for training in adult cardiovascular medicine core cardiology training (COCATS 3) (revision of the 2002 COCATS training statement), J Am Coll Cardiol 51 (2008) 335-338.
5. A. Gruentzig, Percutaneous dilatation of experimental coronary artery stenosis: description of a new catheter system, Klin Wochenschr 54 (1976) 543-545.
6. A. Gruentzig, Transluminal dilatation of coronary-artery stenosis, Lancet 1 (1978) 263.
7. P.W. Serruys, P. de Jaegere, F. Kiemeneij, Benestent Study Group, et al., A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease, N Engl J Med 331 (1994) 489-495.
8. D.R. Holmes Jr., M.B. Leon, J.W. Moses, et al., Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis, Circulation 109 (2004) 634-640.
9. H.I. Kim, K. Ishihara, S. Lee, et al., Tissue response to poly(L-lactic acid)-based blend with phospholipid polymer for biodegradable cardiovascular stents, Biomaterials 32 (2011) 2241-2247.
10. E.P. Navarese, J. Kubica, F. Castriota, et al., Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials, EuroIntervention 7 (2011) 985-994.
11. P.W. Serruys, M.C. Morice, A.P. Kappetein, et al., Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease, N Engl J Med 360 (2009) 961-972.
12. J.L. Ferreiro, D.J. Angiolillo, New directions in antiplatelet therapy, Circ Cardiovasc Interv 5 (2012) 433-445.
13. L. Wallentin, R.C. Becker, A. Budaj, et al., Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med 361 (2009) 1045-1057.
14. S.D. Wiviott, E. Braunwald, C.H. McCabe, et al., Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med 357 (2007) 2001-2015.
15. J. Escaned, N. Gonzalo, Lessons learned from advanced intracoronary imaging in patients with acute myocardial infarction, J Cardiovasc Med (Hagerstown) 12 (2011) 868-877.
16. P.A. Tonino, B. De Bruyne, N.H. Pijls, et al., Fractional flow reserve versus angiography for guiding percutaneous coronary intervention, N Engl J Med 360 (2009) 213-224.
17. B. De Bruyne, N.H. Pijls, B. Kalesan, et al., Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease, N Engl J Med 367 (2012) 991-1001.
18. S.S. Naidu, Novel percutaneous cardiac assist devices: the science of and indications for hemodynamic support, Circulation 123 (2011) 533-543.
19. S.E. Kimmel, A.R. Localio, R.J. Krone, et al., The effects of contemporary use of coronary stents on in-hospital mortality, J Am Coll Cardiol 37 (2001) 499-504.
20. D.E. Winchester, X. Wen, W.D. Brearley, et al., Efficacy and safety of glycoprotein IIb/IIIa inhibitors during elective coronary revascularization: a meta-analysis of randomized trials performed in the era of stents and thienopyridines, J Am Coll Cardiol 57 (2011) 1190-1199.
21. N.R. Desai, D.L. Bhatt, The state of periprocedural antiplatelet therapy after recent trials, J Am Coll Cardiol Intv 3 (2010) 571-583.
22. A.A. Bavry, D.J. Kumbhani, D.L. Bhatt, Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials, Eur Heart J 29 (2008) 2989-3001.
23. D.S. Baim, D. Wahr, B. George, et al., Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts, Circulation 105 (2002) 1285-1290.
24. S.C. Smith Jr., J.T. Dove, A.K. Jacobs, et al., ACC/AHA guidelines for percutaneous coronary interventions (revision of the 1993 PTCA guidelines): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol 37, 2001. 2239i-lxvi.
25. S.C. Smith Jr., T.E. Feldman, J.W. Hirshfeld Jr., et al., ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol 47 (2006) e1-e121.
26. S. Nakamura, P. Hall, A. Gaglione, et al., High pressure assisted coronary stent implantation accomplished without intravascular ultrasound guidance and subsequent anticoagulation, J Am Coll Cardiol 29 (1997) 21-27.
27. S. Sonoda, Y. Morino, J. Ako, et al., Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial, J Am Coll Cardiol 43 (2004) 1959-1963.
28. J.S. Alpert, K. Thygesen, E. Antman, et al., Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial Infarction, J Am Coll Cardiol 36 (2000) 959-969.
29. K. Thygesen, J.S. Alpert, H.D. White, et al., Universal definition of myocardial infarction, Circulation 116 (2007) 2634-2653.
30. K. Thygesen, J.S. Alpert, A.S. Jaffe, et al., ESC/ACCF/AHA/WHF expert consensus document: third universal definition of myocardial infarction, J Am Coll Cardiol 60 (2012) 1581-1598.
31. E.D. Peterson, D. Dai, E.R. DeLong, et al., Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry, J Am Coll Cardiol 55 (2010) 1923-1932.
32. S.G. Ellis, M.H. Shishehbor, S.R. Kapadia, et al., Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators, J Am Coll Cardiol Intv 4 (2011) 442-448.
33. M.A. Kutcher, L.W. Klein, F.S. Ou, et al., Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR), J Am Coll Cardiol 54 (2009) 16-24.
34. A. Aggarwal, D. Dai, J.S. Rumsfeld, et al., Incidence and predictors of stroke associated with percutaneous coronary intervention, Am J Cardiol 104 (2009) 349-353.
35. S. Dukkipati, W.W. O'Neill, K.J. Harjai, et al., Characteristics of cerebrovascular accidents after percutaneous coronary interventions, J Am Coll Cardiol 43 (2004) 1161-1167.
36. F. Feit, M.D. Voeltz, M.J. Attubato, et al., Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 trial, Am J Cardiol 100 (2007) 1364-1369.
37. S.V. Manoukian, F. Feit, R. Mehran, et al., Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY trial, J Am Coll Cardiol 49 (2007) 1362-1368.
38. R. Mehran, S.J. Pocock, E. Nikolsky, et al., A risk score to predict bleeding in patients with acute coronary syndromes, J Am Coll Cardiol 55 (2010) 2556-2566.
39. E. Nikolsky, R. Mehran, G. Dangas, et al., Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach, Eur Heart J 28 (2007) 1936-1945.
40. S.G. Ellis, M.G. Vandormael, M.J. Cowley, Multivessel Angioplasty Prognosis Study Group, et al., Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection, Circulation 82 (1990) 1193-1202.
41. M. Singh, R.J. Lennon, D.R. Holmes Jr., et al., Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention, J Am Coll Cardiol 40 (2002) 387-393.
42. K. Tan, N. Sulke, N. Taub, et al., Clinical and lesion morphologic determinants of coronary angioplasty success and complications: current experience, J Am Coll Cardiol 25 (1995) 855-865.
43. T.J. Ryan, W.B. Bauman, J.W. Kennedy, et al., Guidelines for percutaneous transluminal coronary angioplasty: a report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty), Circulation 88 (1993) 2987-3007.
44. R.J. Krone, R.E. Shaw, L.W. Klein, et al., Evaluation of the American College of Cardiology/American Heart Association and the Society for Coronary Angiography and Interventions lesion classification system in the current "stent era" of coronary interventions (from the ACC-National Cardiovascular Data Registry), Am J Cardiol 92 (2003) 389-394.
45. F.S. Resnic, S.L. Normand, T.C. Piemonte, et al., Improvement in mortality risk prediction after percutaneous coronary intervention through the addition of a "compassionate use" variable to the National Cardiovascular Data Registry CathPCI Dataset: a study from the Massachusetts Angioplasty Registry, J Am Coll Cardiol 57 (2011) 904-911.
46. S.E. Kimmel, J.A. Berlin, B.L. Strom, et al., Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice, J Am Coll Cardiol 26 (1995) 931-938.
47. R.J. Krone, W.K. Laskey, C. Johnson, et al., A simplified lesion classification for predicting success and complications of coronary angioplasty, Am J Cardiol 85 (2000) 1179-1184.
48. M.C. Morice, P.W. Serruys, A.P. Kappetein, et al., Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial, Circulation 121 (2010) 2645-2653.
49. A.P. Kappetein, T.E. Feldman, M.J. Mack, et al., Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial, Eur Heart J 32 (2011) 2125-2134.
50. P.W. Serruys, Y. Onuma, S. Garg, et al., Assessment of the SYNTAX score in the Syntax study, EuroIntervention 5 (2009) 50-56.
51. T.M. Bashore, S. Balter, A. Barac, et al., 2012 American College of Cardiology Foundation/Society for Cardiovascular Angiography and Interventions expert consensus document on cardiac catheterization laboratory standards update: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents, J Am Coll Cardiol 59 (2012) 2221-2305.
52. M.R. Patel, G.J. Dehmer, J.W. Hirshfeld, et al., ACCF/SCAI/STS/AATS/AHA/ ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography Imaging, J Am Coll Cardiol 59 (2012) 857-881.
53. T. Aversano, L.T. Aversano, E. Passamani, et al., Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: a randomized controlled trial, JAMA 287 (2002) 1943-1951.
54. G.J. Dehmer, J. Blankenship, T.P. Wharton Jr., et al., The current status and future direction of percutaneous coronary intervention without on-site surgical backup: an expert consensus document from the Society for Cardiovascular Angiography and Interventions, Catheter Cardiovasc Interv 69 (2007) 471-478.
55. T. Melberg, D.W. Nilsen, A.I. Larsen, et al., Nonemergent coronary angioplasty without on-site surgical backup: a randomized study evaluating outcomes in low-risk patients, Am Heart J 152 (2006) 888-895.
56. P.P. Singh, M. Singh, U.S. Bedi, et al., Outcomes of nonemergent percutaneous coronary intervention with and without on-site surgical backup: a meta-analysis, Am J Ther 18 (2011) e22-e28.
57. M. Moscucci, K.A. Eagle, D. Share, et al., Public reporting and case selection for percutaneous coronary interventions: an analysis from two large multicenter percutaneous coronary intervention databases, J Am Coll Cardiol 45 (2005) 1759-1765.
58. E.L. Hannan, C. Wu, G. Walford, et al., Volume-outcome relationships for percutaneous coronary interventions in the stent era, Circulation 112 (2005) 1171-1179.
59. M. Moscucci, E.K. Rogers, C. Montoye, et al., Association of a continuous quality improvement initiative with practice and outcome variations of contemporary percutaneous coronary interventions, Circulation 113 (2006) 814-822.
60. K.A. Tiroch, N. Arora, M.E. Matheny, et al., Risk predictors of retroperitoneal hemorrhage following percutaneous coronary intervention, Am J Cardiol 102 (2008) 1473-1476.
61. R. Mehran, E.D. Aymong, E. Nikolsky, et al., A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation, J Am Coll Cardiol 44 (2004) 1393-1399.
62. S.K. Mehta, A.D. Frutkin, J.B. Lindsey, et al., Bleeding in patients undergoing percutaneous coronary intervention: the development of a clinical risk algorithm from the National Cardiovascular Data Registry, Circ Cardiovasc Interv 2 (2009) 222-229.
63. H.S. Luft, J.P. Bunker, A.C. Enthoven, Should operations be regionalized? The empirical relation between surgical volume and mortality, N Engl J Med 301 (1979) 1364-1369.
64. T.J. Ryan, D.P. Faxon, R.M. Gunnar, et al., Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty), Circulation 78 (1988) 486-502.
65. T.J. Ryan, F.J. Klocke, W.A. Reynolds, Clinical competence in percutaneous transluminal coronary angioplasty: a statement for physicians from the ACP/ACC/AHA Task Force on Clinical Privileges in Cardiology, J Am Coll Cardiol 15 (1990) 1469-1474.
66. R.G. Brindis, W.S. Weintraub, R.A. Dudley, Volume as a surrogate for percutaneous coronary intervention quality: is this the right measuring stick?, Am Heart J 146 (2003) 932-934.
67. S.F. Khuri, W.G. Henderson, The case against volume as a measure of quality of surgical care, World J Surg 29 (2005) 1222-1229.
68. A.J. Hartz, E.M. Kuhn, K.L. Kayser, et al., Assessing providers of coronary revascularization: a method for peer review organizations, Am J Public Health 82 (1992) 1631-1640.
69. J.L. Ritchie, K.A. Phillips, H.S. Luft, Coronary angioplasty: statewide experience in California, Circulation 88 (1993) 2735-2743.
70. J.G. Jollis, E.D. Peterson, E.R. DeLong, et al., The relation between the volume of coronary angioplasty procedures at hospitals treating Medicare beneficiaries and short-term mortality, N Engl J Med 331 (1994) 1625-1629.
71. J.G. Jollis, E.D. Peterson, C.L. Nelson, et al., Relationship between physician and hospital coronary angioplasty volume and outcome in elderly patients, Circulation 95 (1997) 2485-2491.
72. E.L. Hannan, M. Racz, T.J. Ryan, et al., Coronary angioplasty volume-outcome relationships for hospitals and cardiologists, JAMA 277 (1997) 892-898.
73. V. Ho, Evolution of the volume-outcome relation for hospitals performing coronary angioplasty, Circulation 101 (2000) 1806-1811.
74. S.E. Kimmel, W.H. Sauer, C. Brensinger, et al., Relationship between coronary angioplasty laboratory volume and outcomes after hospital discharge, Am Heart J 143 (2002) 833-840.
75. A.J. Epstein, S.S. Rathore, K.G. Volpp, et al., Hospital percutaneous coronary intervention volume and patient mortality, 1998 to 2000: does the evidence support current procedure volume minimums?, J Am Coll Cardiol 43 (2004) 1755-1762.
76. J.S. Carey, B. Danielsen, J.P. Gold, et al., Procedure rates and outcomes of coronary revascularization procedures in California and New York, J Thorac Cardiovasc Surg 129 (2005) 1276-1282.
77. K.R. Burton, R. Slack, K.G. Oldroyd, et al., Hospital volume of throughput and periprocedural and medium-term adverse events after percutaneous coronary intervention: retrospective cohort study of all 17,417 procedures undertaken in Scotland, 1997-2003, Heart 92 (2006) 1667-1672.
78. V. Allareddy, V. Allareddy, B.R. Konety, Specificity of procedure volume and in-hospital mortality association, Ann Surg 246 (2007) 135-139.
79. R. Zahn, M. Gottwik, M. Hochadel, et al., Volume-outcome relation for contemporary percutaneous coronary interventions (PCI) in daily clinical practice: is it limited to high-risk patients? Results from the Registry of Percutaneous Coronary Interventions of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK), Heart 94 (2008) 329-335.
80. H.C. Lin, H.C. Lee, C.H. Chu, The volume-outcome relationship of percutaneous coronary intervention: can current procedure volume minimums be applied to a developing country?, Am Heart J 155 (2008) 547-552.
81. M. Madan, J. Nikhil, A.S. Hellkamp, et al., Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) study, Can J Cardiol 25 (2009) e269-e272.
82. P.N. Post, M. Kuijpers, T. Ebels, et al., The relation between volume and outcome of coronary interventions: a systematic review and meta-analysis, Eur Heart J 31 (2010) 1985-1992.
83. G.J. Dehmer, W.D. Weaver, M.T. Roe, et al., A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry 2010 through June 2011, J Am Coll Cardiol 60 (2012) 2017-2031.
84. P.D. McGrath, D.E. Wennberg, J.D. Dickens Jr., et al., Relation between operator and hospital volume and outcomes following percutaneous coronary interventions in the era of the coronary stent, JAMA 284 (2000) 3139-3144.
85. M. Moscucci, D. Share, D. Smith, et al., Relationship between operator volume and adverse outcome in contemporary percutaneous coronary intervention practice: an analysis of a quality-controlled multicenter percutaneous coronary intervention clinical database, J Am Coll Cardiol 46 (2005) 625-632.
86. K.E. Minges, Y. Wang, J.A. Dodson, et al., Physician annual volume and in-hospital mortality following percutaneous coronary intervention: a report from the NCDR: American Heart Association 2011 Annual Scientific Sessions, Circulation 124 (2011) A16550. Abstract.
87. J. Maroney, S. Khan, W. Powell, et al., Current operator volumes of invasive coronary procedures in Medicare patients: implications for future manpower needs in the catheterization laboratory, Catheter Cardiovasc Interv 81 (2013) 34-39.
88. M. Tsuchihashi, H. Tsutsui, H. Tada, et al., Volume-outcome relation for hospitals performing angioplasty for acute myocardial infarction: results from the Nationwide Japanese Registry, Circ J 68 (2004) 887-891.
89. M.T. Ohtsuka, M. Toyama, K. Obara, et al., Effect of hospital case volume on treatment and in-hospital outcomes in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Results from the Ibaraki Coronary Artery Disease Study (ICAS) Registry, Int Heart J 49 (2008) 249-260.
90. J. Shiraishi, Y. Kohno, T. Sawada, et al., Effects of hospital volume of primary percutaneous coronary interventions on angiographic results and in-hospital outcomes for acute myocardial infarction, Circ J 72 (2008) 1041-1046.
91. D.J. Kumbhani, C.P. Cannon, G.C. Fonarow, et al., Association of hospital primary angioplasty volume in ST-segment elevation myocardial infarction with quality and outcomes, JAMA 302 (2009) 2207-2213.
92. A.J. Tiefenbrunn, N.C. Chandra, W.J. French, et al., Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2), J Am Coll Cardiol 31 (1998) 1240-1245.
93. R. Zahn, A. Vogt, K. Seidl, et al., Balloon dilatation in acute myocardial infarct in routine clinical practice: results of the register of the Working Society of Leading Cardiologic Hospital Physicians in 4,625 patients, Z Kardiol 86 (1997) 712-721.
94. D.J. Magid, B.N. Calonge, J.S. Rumsfeld, et al., Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy, JAMA 284 (2000) 3131-3138.
95. J.G. Canto, N.R. Every, D.J. Magid, National Registry of Myocardial Infarction 2 Investigators, et al., The volume of primary angioplasty procedures and survival after acute myocardial infarction, N Engl J Med 342 (2000) 1573-1580.
96. C.P. Cannon, C.M. Gibson, C.T. Lambrew, et al., Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction, JAMA 283 (2000) 2941-2947.
97. B.A. Vakili, R. Kaplan, D.L. Brown, Volume-outcome relation for physicians and hospitals performing angioplasty for acute myocardial infarction in New York state, Circulation 104 (2001) 2171-2176.
98. R. Zahn, A. Vogt, U. Zeymer, et al., In-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhausarzte, Heart 91 (2005) 1041-1046.
99. V.S. Srinivas, S.M. Hailpern, E. Koss, et al., Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty, J Am Coll Cardiol 53 (2009) 574-579.
100. H. Kuwabara, K. Fushimi, S. Matsuda, Relationship between hospital volume and outcomes following primary percutaneous coronary intervention in patients with acute myocardial infarction, Circ J 75 (2011) 1107-1112.
101. B.A. Vakili, D.L. Brown, Relation of total annual coronary angioplasty volume of physicians and hospitals on outcomes of primary angioplasty for acute myocardial infarction (data from the 1995 Coronary Angioplasty Reporting System of the New York State Department of Health), Am J Cardiol 91 (2003) 726-728.
102. C. Spaulding, M.C. Morice, B. Lancelin, et al., Is the volume-outcome relation still an issue in the era of PCI with systematic stenting? Results of the greater Paris area PCI registry, Eur Heart J 27 (2006) 1054-1060.
103. D.M. Shahian, G.S. Meyer, R.W. Yeh, et al., Percutaneous coronary interventions without on-site cardiac surgical backup, N Engl J Med 366 (2012) 1814-1823.
104. E.C. Keeley, J.A. Boura, C.L. Grines, Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials, Lancet 361 (2003) 13-20.
105. T.P. Wharton Jr., N.S. McNamara, F.A. Fedele, et al., Primary angioplasty for the treatment of acute myocardial infarction: experience at two community hospitals without cardiac surgery, J Am Coll Cardiol 33 (1999) 1257-1265.
106. H.H. Ting, G. Raveendran, R.J. Lennon, et al., A total of 1,007 percutaneous coronary interventions without onsite cardiac surgery: acute and long-term outcomes, J Am Coll Cardiol 47 (2006) 1713-1721.
107. T.P. Wharton Jr., Nonemergent percutaneous coronary intervention with off-site surgery backup: an emerging new path to access, Crit Pathw Cardiol 4 (2005) 98-106.
108. G.J. Dehmer, M.A. Kutcher, S.K. Dey, et al., Frequency of percutaneous coronary interventions at facilities without on-site cardiac surgical backup: a report from the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR), Am J Cardiol 99 (2007) 329-332.
109. J. Carlsson, S.N. James, E. Stahle, et al., Outcome of percutaneous coronary intervention in hospitals with and without on-site cardiac surgery standby, Heart 93 (2007) 335-338.
110. M.I. Zia, H.C. Wijeysundera, J.V. Tu, et al., Percutaneous coronary intervention with vs without on-site cardiac surgery backup: a systematic review and meta-analysis, Can J Cardiol 27, 2011. 664-16.
111. M. Singh, D.R. Holmes Jr., G.J. Dehmer, et al., Percutaneous coronary intervention at centers with and without on-site surgery: a meta-analysis, JAMA 306 (2011) 2487-2494.
112. M. Singh, B.J. Gersh, R.J. Lennon, et al., Outcomes of a system-wide protocol for elective and nonelective coronary angioplasty at sites without on-site surgery: the Mayo Clinic experience, Mayo Clin Proc 84 (2009) 501-508.
113. T. Aversano, C.C. Lemmon, L. Liu, Outcomes of PCI at hospitals with or without on-site cardiac surgery, N Engl J Med 366 (2012) 1792-1802.
114. Y.B. Pride, J.G. Canto, P.D. Frederick, et al., Outcomes among patients with ST-segment-elevation myocardial infarction presenting to interventional hospitals with and without on-site cardiac surgery, Circ Cardiovasc Qual Outcomes 2 (2009) 574-582.
115. R.W. Yeh, S. Sidney, M. Chandra, et al., Population trends in the incidence and outcomes of acute myocardial infarction, N Engl J Med 362 (2010) 2155-2165.
116. J.G. Jollis, C.B. Granger, T.D. Henry, et al., Systems of care for ST-segment-elevation myocardial infarction: a report from the American Heart Association's Mission: Lifeline, Circ Cardiovasc Qual Outcomes 5 (2012) 423-428.
117. S.M. Kansagra, L.H. Curtis, K.J. Anstrom, et al., Trends in operator and hospital procedure volume and outcomes for percutaneous transluminal coronary angioplasty, 1996 to 2001, Am J Cardiol 99 (2007) 339-343.
118. J.G. Jollis, M. Ancukiewicz, E.R. DeLong, et al., Discordance of databases designed for claims payment versus clinical information systems: implications for outcomes research, Ann Intern Med 119 (1993) 844-850.
119. F.S. Resnic, F.G. Welt, The public health hazards of risk avoidance associated with public reporting of risk-adjusted outcomes in coronary intervention, J Am Coll Cardiol 53 (2009) 825-830.
120. The Leapfrog Group. Available at: http://www.leapfroggroup.org/. Accessed October 14, 2012.
121. The Leapfrog Group. Leapfrog Evidence-Based Hospital Referral Fact Sheet. Available at: http://www.leapfroggroup.org/media/file/Leapfrog-Evidence-based- Hospital-Referral-Fact-Sheet.pdf. Accessed October 14, 2012.
122. W. Wijns, P. Kolh, N. Danchin, et al., Guidelines on myocardial revascularization, Eur Heart J 31 (2010) 2501-2555.
123. K.F. Fox, Simulation-based learning in cardiovascular medicine: benefits for the trainee, the trained and the patient, Heart 98 (2012) 527-528.
124. R. De Ponti, R. Marazzi, S. Ghiringhelli, et al., Superiority of simulator-based training compared with conventional training methodologies in the performance of transseptal catheterization, J Am Coll Cardiol 58 (2011) 359-363.
125. W. Voelker, S. Maier, B. Lengenfelder, et al., Improved quality of coronary diagnostics and interventions by virtual reality simulation, Herz 36 (2011) 430-435.
126. J. Marco, D.R. Holmes Jr., Simulation: present and future roles, J Am Coll Cardiol Intv 1 (2008) 590-592.
127. R.S. Lipner, J.C. Messenger, R. Kangilaski, et al., A technical and cognitive skills evaluation of performance in interventional cardiology procedures using medical simulation, Simul Healthc 5 (2010) 65-74.
128. L.W. Klein, B.F. Uretsky, C. Chambers, et al., Quality assessment and improvement in interventional cardiology: a position statement of the Society of Cardiovascular Angiography and Interventions, part 1: standards for quality assessment and improvement in interventional cardiology, Catheter Cardiovasc Interv 77 (2011) 927-935.
129. L. Campeau, Percutaneous radial artery approach for coronary angiography, Cathet Cardiovasc Diagn 16 (1989) 3-7.
130. F. Kiemeneij, G.J. Laarman, Transradial artery Palmaz-Schatz coronary stent implantation: results of a single-center feasibility study, Am Heart J 130 (1995) 14-21.
131. C. Lotan, Y. Hasin, M. Mosseri, et al., Transradial approach for coronary angiography and angioplasty, Am J Cardiol 76 (1995) 164-167.
132. C. Spaulding, T. Lefevre, F. Funck, et al., Left radial approach for coronary angiography: results of a prospective study, Cathet Cardiovasc Diagn 39 (1996) 365-370.
133. L. Wang, Y. Yang, Y. Zhou, et al., Prevalence of transradial coronary angiography and intervention in China: report from the Transradial coronary intervention Registration Investigation in China (TRI-China), Int J Cardiol 145 (2010) 246-247.
134. S.V. Rao, F.S. Ou, T.Y. Wang, et al., Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry, J Am Coll Cardiol Intv 1 (2008) 379-386.
135. D. Feldman, R.V. Swaminathan, L.A. Kaltenbach, et al., Adoption of radial access and comparison of outcomes to femoral approach in percutaneous coronary intervention in the United States: an updated report from the National Cardiovascular Data Registry (2007-2011): American Heart Association 2012 Annual Scientific Sessions, Circulation 126 (2012) A12423. Abstract.
136. S.S. Jolly, S. Yusuf, J. Cairns, et al., Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial, Lancet 377 (2011) 1409-1420.
137. C.J. Cooper, R.A. El-Shiekh, D.J. Cohen, et al., Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison, Am Heart J 138 (1999) 430-436.
138. M. Kindel, R. Ruppel, Hydrophilic-coated sheaths increase the success rate of transradial coronary procedures and reduce patient discomfort but do not reduce the occlusion rate: randomized single-blind comparison of coated vs. non-coated sheaths, Clin Res Cardiol 97 (2008) 609-614.
139. W.T. Ball, W. Sharieff, S.S. Jolly, et al., Characterization of operator learning curve for transradial coronary interventions, Circ Cardiovasc Interv 4 (2011) 336-341.
140. M. Uhlemann, S. Mobius-Winkler, M. Mende, et al., The Leipzig prospective vascular ultrasound registry in radial artery catheterization: impact of sheath size on vascular complications, J Am Coll Cardiol Intv 5 (2012) 36-43.
141. R.P. Caputo, J.A. Tremmel, S. Rao, et al., Transradial arterial access for coronary and peripheral procedures: executive summary by the Transradial Committee of the SCAI, Catheter Cardiovasc Interv 78 (2011) 823-839.
142. J.W. Hirshfeld Jr., J.S. Banas Jr., B.H. Brundage, et al., American College of Cardiology training statement on recommendations for the structure of an optimal adult interventional cardiology training program: a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents, J Am Coll Cardiol 34 (1999) 2141-2147.
143. G.J. Dehmer, R.G. Brindis, Quality of care in interventional cardiology, in:, E.J. Topol, (Ed.), Textbook of Interventional Cardiology, Saunders Elsevier, Philadelphia, Pa, 2011, pp. 873-893.
144. A.K. Jacobs, J.D. Babb, J.W. Hirshfeld Jr., et al., Task Force 3: training in diagnostic and interventional cardiac catheterization, J Am Coll Cardiol 51 (2008) 355-361.
145. B.F. Uretsky, F.W. Wang, Implementation and application of a continuous quality improvement (CQI) program for the cardiac catheterization laboratory: one institution's 10-year experience, Catheter Cardiovasc Interv 68 (2006) 586-595.
146. H.V. Anderson, R.E. Shaw, R.G. Brindis, et al., Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines, Circulation 112 (2005) 2786-2791.
147. W.S. Weintraub, M.V. Grau-Sepulveda, J.M. Weiss, et al., Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry, Circulation 125 (2012) 1501-1510.
148. J.N. Hamburger, S.J. Walsh, R. Khurana, et al., Percutaneous coronary intervention and 30-day mortality: the British Columbia PCI risk score, Catheter Cardiovasc Interv 74 (2009) 377-385.
149. S. Chowdhary, J. Ivanov, K. Mackie, et al., The Toronto score for
150. J.R. Brown, J.T. DeVries, W.D. Piper, et al., Serious renal dysfunction after percutaneous coronary interventions can be predicted, Am Heart J 155 (2008) 260-266.
151. M. Singh, E.D. Peterson, S. Milford-Beland, et al., Validation of the Mayo clinic risk score for in-hospital mortality after percutaneous coronary interventions using the National Cardiovascular Data Registry, Circ Cardiovasc Interv 1 (2008) 36-44.
152. M. Singh, C.S. Rihal, R.J. Lennon, et al., Bedside estimation of risk from percutaneous coronary intervention: the new Mayo Clinic risk scores, Mayo Clin Proc 82 (2007) 701-708.
153. C. Wu, E.L. Hannan, G. Walford, et al., A risk score to predict in-hospital mortality for percutaneous coronary interventions, J Am Coll Cardiol 47 (2006) 654-660.
154. P.S. Douglas, R.G. Brindis, President's page: a question of quality: why national benchmarking?, J Am Coll Cardiol 47 (2006) 1076-1078.
155. L.W. Klein, P. Kolm, X. Xu, et al., A longitudinal assessment of coronary interventional program quality: a report from the American College of Cardiology-National Cardiovascular Data Registry, J Am Coll Cardiol Intv 2 (2009) 136-143.
156. G.J. Dehmer, J.W. Hirshfeld, W.J. Oetgen, et al., CathKIT: improving quality in the cardiac catheterization laboratory, J Am Coll Cardiol 43 (2004) 893-899.
157. R.G. Brindis, S. Fitzgerald, H.V. Anderson, et al., The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository, J Am Coll Cardiol 37 (2001) 2240-2245.
158. R.G. Brindis, G.J. Dehmer, Continuous quality improvement in the cardiac catheterization laboratory: are the benefits worth the cost and effort?, Circulation 113 (2006) 767-770.
159. U. Sigwart, Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy, Lancet 346 (1995) 211-214.
160. J.C. Lyne, T. Kilpatrick, A. Duncan, et al., Long-term follow-up of the first patients to undergo transcatheter alcohol septal ablation, Cardiology 116 (2010) 168-173.
161. S.F. Nagueh, B.M. Groves, L. Schwartz, et al., Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy: a multicenter North American registry, J Am Coll Cardiol 58 (2011) 2322-2328.
162. P. Sorajja, S.R. Ommen, D.R. Holmes Jr., et al., Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy, Circulation 126 (2012) 2374-2380.
163. B.J. Gersh, B.J. Maron, R.O. Bonow, et al., 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol 58 (2011) e212-e260.
164. H.C. Herrmann, S. Baxter, C.E. Ruiz, et al., Results of the Society of Cardiac Angiography and Interventions survey of physicians and training directors on procedures for structural and valvular heart disease, Catheter Cardiovasc Interv 76 (2010) E106-E110.
165. S.S. Kim, B.P. Knight, Alcohol ablation for ventricular tachycardia: a distillation of modern cases, Heart Rhythm 5 (2008) 69-70.
166. F. Sacher, P. Sobieszczyk, U. Tedrow, et al., Transcoronary ethanol ventricular tachycardia ablation in the modern electrophysiology era, Heart Rhythm 5 (2008) 62-68.
167. R.M. John, W.G. Stevenson, Catheter-based ablation for ventricular arrhythmias, Curr Cardiol Rep 13 (2011) 399-406.
168. C.A. Warnes, R.G. Williams, T.M. Bashore, et al., ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol 52 (2008) e143-e263.